AntineoplasticsMyelosuppression: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1983卷 / 1期

关键词：

D O I：

10.1007/s40278-023-49409-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：60 / 60

相关论文

共 50 条

[41] AntineoplasticsMyelosuppression, thrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2021, 1865 (1) : 60 - 60
[42] AntineoplasticsMyelosuppression, GI upset and fatigue: case report
Reactions Weekly, 2017, 1639 (1) : 41 - 41
[43] AntineoplasticsMyelosuppression, acrocyanosis and erythema pernio: case report
Reactions Weekly, 2023, 1965 (1) : 62 - 62
[44] AntineoplasticsMyelosuppression and delirium in an elderly patient: case report
Reactions Weekly, 2011, 1367 (1) : 7 - 7
[45] AntineoplasticsMyelosuppression and COVID-19: case report
Reactions Weekly, 2020, 1835 (1) : 35 - 35
[46] AntineoplasticsMyelosuppression
Reactions Weekly, 2024, 2006 (1) : 72 - 72
[47] AntineoplasticsMyelosuppression, gingival bleeding and lack of efficacy: case report
Reactions Weekly, 2025, 2055 (1) : 46 - 46
[48] AntineoplasticsMyelosuppression, renal impairment and lack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 63 - 63
[49] ImmunosuppressantsVarious toxicities: 2 case reports: 2 case reports
Reactions Weekly, 2019, 1769 (1) : 253 - 253
[50] AntineoplasticsMyelosuppression following off label use: case report
Reactions Weekly, 2021, 1844 (1) : 46 - 46

← 1 2 3 4 5 →